Our findings demonstrated a marked increase in CLPTM1L mRNA expression levels in both HeLa and C33A cervical cancer cell lines, as well as in cervical carcinoma tissues, when compared to normal counterparts. The gene discussed is CLPTM1L; the disease is cervical cancer.